Assistant Professor of Pharmacy and Epidemiology
Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
Chintan Dave, a pharmacoepidemiologist and health service researcher, joined PETS and Ernest Mario College of Pharmacy in 2019 as an Assistant Professor of Pharmacy. He received his pharmacy degree from St. Louis College of Pharmacy (2012), his Ph.D. in Pharmacoepidemiology from University of Florida (2017) and post-doctoral training from Harvard Medical School (2019). He has conducted several observational studies on the comparative safety and effectiveness of pharmaceuticals. His recent work has focused on the safety and cardiovascular effectiveness of Sodium-glucose co-transporter-2 inhibitors, a newer class of agents used for the management of diabetes. Broadly, his work leverages large observational databases and applies advanced statistical and epidemiological methods for confounding adjustment, within the areas of cardiometabolic and geriatric pharmacoepidemiology. He has led projects that have culminated in first author publications in leading journals like the New England Journal of Medicine, Annals of Internal Medicine and JAMA: Internal Medicine. He is the Assistant Director for industry fellowships at PETS, and the Academic Director at the Rutgers Center for Health Outcomes, Policy, and Economics (HOPE). Currently, he serves as the PI of an R01 award from NHLBI and a research award from JDRF.
